Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Blood|February 21, 2019
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaTayla B Heavican, Alyssa Bouska, Jiayu Yu, et al.
Science Translational Medicine|February 4, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cellsIvan J Cohen, Audrey C Bochi-Layec, Jean Lemoine, et al.
American Journal of Hematology|January 13, 2024
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomesJames R Cerhan, Matthew J Maurer, Brian K Link, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Cancer Research|November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft ModelsTerrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Cell Reports. Medicine|March 27, 2025
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilitiesDanilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, et al.
Blood|August 24, 2022
Genomic profiling for clinical decision making in lymphoid neoplasmsLaurence de Leval, Ash A Alizadeh, P Leif Bergsagel, et al.
Blood|October 15, 2021
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, et al.
Cancer Cell|April 13, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Cancer Cell|August 2, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Blood|February 21, 2019
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphomaTayla B Heavican, Alyssa Bouska, Jiayu Yu, et al.
Science Translational Medicine|February 4, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cellsIvan J Cohen, Audrey C Bochi-Layec, Jean Lemoine, et al.
American Journal of Hematology|January 13, 2024
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomesJames R Cerhan, Matthew J Maurer, Brian K Link, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Cancer Research|November 3, 2017
PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft ModelsTerrence F Meehan, Nathalie Conte, Theodore Goldstein, et al.
Cell Reports. Medicine|March 27, 2025
A patient-derived T cell lymphoma biorepository uncovers pathogenetic mechanisms and host-related therapeutic vulnerabilitiesDanilo Fiore, Luca Vincenzo Cappelli, Liu Zhaoqi, et al.
Blood|August 24, 2022
Genomic profiling for clinical decision making in lymphoid neoplasmsLaurence de Leval, Ash A Alizadeh, P Leif Bergsagel, et al.
Blood|October 15, 2021
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, et al.
Cancer Cell|April 13, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Cancer Cell|August 2, 2016
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C Townsend, Mark A Murakami, Alexandra Christodoulou, et al.
Pageof 24